SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Amprius Technologies, Inc. engages in the development, manufacture, and market of lithium-ion batteries for mobility applications, including the aviation, electric vehicle and light electric vehicle industries. It operates through the following geographical segments: North America, EMEA, and Asia Pacific. The company was founded by Mark C. Platshon in 2008 and headquartered in Fremont, CA.

Amprius Technologies Inc

Amprius Technologies is facing significant volatility as investors debate the impact of an activist short seller report alleging order exaggeration, while others view the pullback as a buying opportunity supported by strong fundamental growth and NDAA-compliant defense contracts. The community is focused on separating macro-driven price action and technical warrant-related selling from the company's long-term potential in the high-density battery sector.

Shiba Inu (SHIB) is a decentralized, community-led cryptocurrency ecosystem built on the Ethereum blockchain. Originally launched as a meme-based project, it has evolved into a comprehensive financial ecosystem designed to offer a decentralized alternative to traditional banking. Its main value proposition lies in its transition from a social phenomenon into a functional utility network, supported by a vast global community known as the ShibArmy and a commitment to 100% community ownership with no central leadership.  The ecosystem features its own decentralized exchange, ShibaSwap, where users can trade, provide liquidity, and earn rewards. To address Ethereum’s high costs and slow speeds, the project utilizes Shibarium, a Layer 2 scaling solution that processes transactions faster and more affordably.  The project employs a unique three-token model to manage its economy and governance. SHIB serves as the primary currency for trading and payments, while LEASH offers scarcity-based incentives for dedicated supporters. BONE acts as the governance token, allowing holders to vote on proposals through the Doggy DAO and serving as the native gas token for the Shibarium network.

Shiba Inu

Shiba Inu is currently trending as investors debate its long-term viability, with a vocal segment of the community highlighting alternative meme tokens on other chains as more efficient options for supply burns and utility. Sentiment remains sharply divided between loyalists maintaining a long-term bullish outlook and skeptics who argue the token has lost its momentum and faces persistent downside pressure.

Emergent BioSolutions Inc. engages in the development, manufacture, and commercialization of medical countermeasures. It operates through the following segments: Commercial Product Sales, MCM Product Sales, and Services. The Commercial Product Sales segment includes NARCAN products and other commercial products that were sold as part of the travel health business. The MCM Product Sales segment focuses on the Anthrax - MCM products, Smallpox - MCM products and other products. The Services segment consists of the company’s Bioservices offerings. It offers products for civilian and military populations that address accidental, intentional, and naturally occurring public health threats. The company was founded by Fuad El-Hibri on September 5, 1998 and is headquartered in Gaithersburg, MD.

Emergent Biosolutions Inc

Emergent Biosolutions is experiencing significant volatility as investors monitor a series of new strategic manufacturing contracts and pending financial results, while community sentiment remains divided between those betting on a turnaround under CEO Joe Papa and skeptics wary of dilution and debt levels. Conversations are heavily focused on the company's ability to secure government biodefense contracts, its efforts to stabilize balance sheets, and the potential impact of various infectious disease outbreaks on long-term demand.

AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease. The company was founded by Carl Lars G. Hensen, Kathleen Lisaingo, Kevin Heyries, Véronique Lecault and Daniel Da Costa on November 8, 2012 and is headquartered in Vancouver, Canada.

AbCellera Biologics Inc

AbCellera Biologics is currently in the spotlight as investors track the development of its AI-driven antibody discovery platform and upcoming clinical catalysts, specifically the Phase 2 readout for ABCL635. Community discussion is heavily divided between long-term holders highlighting institutional accumulation and strong financial liquidity, while short-term traders debate the stock's volatility and the impact of the ongoing high short interest.

CrowdStrike Holdings, Inc. provides cybersecurity products and services to stop breaches. It offers cloud-delivered protection across endpoints, cloud workloads, identity and data, and threat intelligence, managed security services, IT operations management, threat hunting, Zero Trust identity protection, and log management. CrowdStrike serves customers worldwide. The company was founded by George P. Kurtz, Gregg Marston, and Dmitri Alperovitch on November 7, 2011 and is headquartered in Austin, TX.

Crowdstrike Holdings Inc - Ordinary Shares - Class A

Crowdstrike Holdings Inc

CrowdStrike is in the spotlight following strong quarterly results and the announcement of a four-for-one stock split, sparking intense debate among investors over whether the company's premium valuation remains justified. While the community highlights its role as a core cybersecurity leader, the stock has experienced significant volatility as traders weigh record-setting growth against high market expectations.

Applied Optoelectronics, Inc. engages in the design and manufacture of optical communications products. Its products include optical devices, such as laser diodes, photodiodes, related modules and circuitry, and equipment for applications in fiber-to-the-home, cable television, point to point communications, and wireless. The company was founded by Chih Hsiang Lin on February 28, 1997 and is headquartered in Sugar Land, TX.

Applied Optoelectronics Inc

Applied Optoelectronics is currently facing high volatility as investors weigh the company's aggressive revenue growth projections against concerns regarding ongoing insider selling and share dilution. The community is sharply divided, with some traders viewing the current pullback as a buying opportunity based on AI infrastructure demand, while others caution that the stock is fundamentally overvalued and prone to further downside.

The Wendy’s Co. engages in operating, developing, and franchising a system of quick-service restaurants. It operates through the following segments: Wendy’s U.S., Wendy’s International, and Global Real Estate and Development. The Wendy’s U.S. segment includes the operation and franchising of Wendy’s restaurants in the U.S. The Wendy’s International segment is involved in the operation and franchising of Wendy’s restaurants in countries and territories other than the U.S. The Global Real Estate and Development segment focuses on real estate activity for owned sites and sites leased from third parties. The company was founded by R. David Thomas on November 15, 1969 and is headquartered in Dublin, OH.

Wendy`s Co - Ordinary Shares - Class A

Wendy's Co

Wendy's ($WEN) is seeing intense retail interest as a potential short squeeze candidate, with investors highlighting its high short interest, deep-value fundamentals, and consistent dividend payments. The community is actively rallying around the stock with 'save Wendy' messaging, comparing its potential setup to past viral short squeezes while tracking institutional movements and upcoming business expansion plans.

Pagaya Technologies Ltd. engages in the development of AI and data networks for the financial industry. Its product deploys data science, machine learning and AI technology to evaluate the customers' applications in real time. The company was founded by Gal Krubiner, Sanjiv Das, Yahav Yulzari, and Avital Pardo on March 20, 2016 and is headquartered in New York, NY.

Pagaya Technologies Ltd - Ordinary Shares - Class A

Pagaya Technologies Ltd

Pagaya Technologies is seeing significant investor attention driven by CEO insider buying and a recent, large-scale asset-backed securitization that has stabilized liquidity. While the community is actively debating the stock's potential for a short squeeze amid heavy short interest, sentiment is polarized between those focused on the company's profitability and those frustrated by recent stock performance following its Russell index removal.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is experiencing significant upward momentum and trending interest as investors speculate on potential Russell 1000 index inclusion and position themselves ahead of anticipated mid-summer catalysts. The community remains hyper-focused on the company's proprietary cancer treatment technology, while simultaneously engaging in intense discussions about squeezing short sellers who remain heavily positioned against the stock.

Taiwan Semiconductor Manufacturing Co., Ltd. engages in the manufacture and sale of integrated circuits and wafer semiconductor devices. Its chips are used in personal computers and peripheral products, information applications, wired and wireless communications systems products, and automotive and industrial equipment including consumer electronics such as smartphones, digital television, game consoles, and digital cameras. The company was founded by Chung Mou Chang on February 21, 1987 and is headquartered in Hsinchu, Taiwan.

Taiwan Semiconductor Manufacturing - ADR

Taiwan Semiconductor Manufacturing is trending as investors weigh its dominant foundry position and advanced packaging role against persistent geopolitical risks and global supply constraints. The community is actively discussing TSMC's critical supply-chain bottleneck, its ability to maintain pricing power amid exploding AI demand, and how it compares to broader semiconductor sector leaders.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

ABVX Investors Have Opportunity to Join Abivax S.A. Fraud Investigation with the Schall Law Firm

ABVX Investors Have Opportunity to Join Abivax S.A. Fraud Investigation with the Schall Law Firm ABVX Investors Have Opportunity to Join Abivax S.A. Fraud Investigation with the Schall Law Firm PR Newswire Los Angeles, June 11, 2026 Los Angeles, June 11, 2026 /PRNewswire/ -- The Schall Law Firm, a...

ABVX DEADLINE: The Gross Law Firm Reminds ABIVAX Societe Anonyme Investors of Upcoming Securities Class Action Deadline

ABVX DEADLINE: The Gross Law Firm Reminds ABIVAX Societe Anonyme Investors of Upcoming Securities Class Action Deadline ABVX DEADLINE: The Gross Law Firm Reminds ABIVAX Societe Anonyme Investors of Upcoming Securities Class Action Deadline PR Newswire NEW YORK, June 9, 2026 NEW YORK, June 9, 2026...

What's Going On With Abivax Stock On Thursday?

Abivax's Phase 3 ulcerative colitis data met remission goals, but cancer cases in the study raised safety questions and analyst caution.read more...

Futures Slide After Broadcom Forecast Miss Chills Tech Euphoria

Futures Slide After Broadcom Forecast Miss Chills Tech Euphoria

 US equity futures are weaker, dragged lower by Tech after a disappointing outlook from?Broadcom triggered doubts that the blistering rally in technology shares had gone too far, a move exacerbated by euphoric positioning...

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Abivax S.A. (Abivax or the Company) (NASDAQ: ABVX) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or...

Navitas Semiconductor, Abivax, MiniMed And Other Big Stocks Moving Higher On Wednesday

Dow falls 296 points. Navitas Semi rises on partnership with Nvidia. Other gainers: ABVX, MMED, KELYB, NN, BVC, MX, ECX, DRTS, RZLT, SYRE, TGTX. read more...

Abivax SA Sponsored ADR (ABVX) Loses 41.4% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

The heavy selling pressure might have exhausted for Abivax SA Sponsored ADR (ABVX) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

Abivax Investigation Initiated: SueWallSt Investigates the Officers and Directors of Abivax (ABVX)

Abivax Investigation Initiated: SueWallSt Investigates the Officers and Directors of Abivax (ABVX) Abivax Investigation Initiated: SueWallSt Investigates the Officers and Directors of Abivax (ABVX) PR Newswire NEW YORK, June 2, 2026 Jefferies downgraded Abivax from Buy to Hold and slashed its price...

ABVX Stock Clocks Worst Day Ever On Malignancy Signal For Drug: ‘Pharma Bro’ Says ‘GLPs Are Doing Fine’ After Similar Fears  

Equity

Shares of ABVX closed down 44% on Tuesday, clocking its worst day ever, on reports of a number of non-melanoma skin cancers and other malignancies observed in its ulcerative colitis trial. 


Abivax Grounded as Cancer Cases Cast a Shadow Over Best-in-Class Trial Data

Abivax Grounded as Cancer Cases Cast a Shadow Over Best-in-Class Trial Data...

Abivax SA engages in the sale, research, distribution, and development of biopharmaceutical products. It offers commercial and development products of anti-viral compounds and human vaccines. The commercialized products include vaccines for typhoid fever, meningococcus, and leptospirosis. The products under development include vaccines for chronic hepatitis B, ebola, and dengue virus. The company was founded by Philippe Pouletty on December 4, 2003 and is headquartered in Paris, France.

Abivax - ADR

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$97.50
Prev Close	$92.37
Open	$93.02
Dividend Yield	0.00%
50-Day Moving Average	$112.06
Beta	0.86
Avg. Volume	1.04M
PE Ratio	-17.58

52-Week High	$148.83
52-Week Low	$7.24
Market Capitalization	$7.37B
EPS (Annual)	-$5.46
Price to Book	14.80
Revenue Per Employee	$0.00

Feed

News

Sentiment

Earnings

Fundamentals

Info

ABVXAbivax - ADR

Latest ABVX News